1349 — Shanghai Fudan-zhangjiang Bio-Pharmaceutical Co Share Price

As of Today at 01:43 UTC, shares in Shanghai Fudan-zhangjiang Bio-Pharmaceutical Co are trading at HK$3.29. This share price information is delayed by 15 minutes.

Shares in Shanghai Fudan-zhangjiang Bio-Pharmaceutical Co last closed at HK$3.29 and the price had moved by +38.24% over the past 365 days. In terms of relative price strength the Shanghai Fudan-zhangjiang Bio-Pharmaceutical Co share price has underperformed the FTSE Developed Asia Pacific Index by -9.01% over the past year.

There is no consensus recommendation for this security.

The Shanghai Fudan-zhangjiang Bio-Pharmaceutical Co dividend yield is 1.03% based on the trailing twelve month period.

Last year, Shanghai Fudan-zhangjiang Bio-Pharmaceutical Co paid a total dividend of CNY0.03, and it currently has a trailing dividend yield of 1.03%. We do not have any data on when Shanghai Fudan-zhangjiang Bio-Pharmaceutical Co is to next pay dividends.

We do not have data on when Shanghai Fudan-zhangjiang Bio-Pharmaceutical Co is to next pay dividends.  The historic dividend yield on Shanghai Fudan-zhangjiang Bio-Pharmaceutical Co shares is currently 1.03%.

To buy shares in Shanghai Fudan-zhangjiang Bio-Pharmaceutical Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

As of the previous close price of HK$3.29, shares in Shanghai Fudan-zhangjiang Bio-Pharmaceutical Co had a market capitalisation of HK$3.41bn.

Here are the trading details for Shanghai Fudan-zhangjiang Bio-Pharmaceutical Co: 

• Country of listing: Hong Kong
• Exchange: HKG
• Ticker Symbol: 1349

Based on an overall assessment of its quality, value and momentum Shanghai Fudan-zhangjiang Bio-Pharmaceutical Co is currently classified as a Falling Star. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

We could not find analyst target price data for this security.

An important predictor of whether a stock price will go up is its track record of momentum.  Price trends tend to persist, so it's worth looking at them when it comes to a share like Shanghai Fudan-zhangjiang Bio-Pharmaceutical Co. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -37.7%.

As of the last closing price of HK$3.29, shares in Shanghai Fudan-zhangjiang Bio-Pharmaceutical Co were trading -0.69% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

The Shanghai Fudan-zhangjiang Bio-Pharmaceutical Co PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at HK$3.29. 

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Shanghai Fudan-zhangjiang Bio-Pharmaceutical Co's management team is headed by: 

• Hai Bo Wang - CHM
• Yan Xue - CFO
• Da Jun Zhao - CCO
• Yi Min Gan - DGM
• Jun Li - DGM
• Xiao Lin Yang - DGM
• Yong Su - EDR
• Ying Ke - NED
• Bo Shen - NED
• Xiao Yang Yu - NED
• Yiu Kin Lam - NID
• Qing Xu - NID
• Chun Bao Yang - NID
• Zhong Hui Zhou - NID